MESO
Price
$16.36
Change
-$0.62 (-3.65%)
Updated
Jul 25 closing price
Capitalization
2.13B
31 days until earnings call
QTTB
Price
$2.21
Change
-$0.10 (-4.33%)
Updated
Jul 25 closing price
Capitalization
26.96M
Interact to see
Advertisement

MESO vs QTTB

Header iconMESO vs QTTB Comparison
Open Charts MESO vs QTTBBanner chart's image
Mesoblast
Price$16.36
Change-$0.62 (-3.65%)
Volume$213.38K
Capitalization2.13B
Q32 Bio
Price$2.21
Change-$0.10 (-4.33%)
Volume$214.1K
Capitalization26.96M
MESO vs QTTB Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. QTTB commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Buy and QTTB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MESO: $16.36 vs. QTTB: $2.21)
Brand notoriety: MESO and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 94% vs. QTTB: 12%
Market capitalization -- MESO: $2.13B vs. QTTB: $26.96M
MESO [@Biotechnology] is valued at $2.13B. QTTB’s [@Biotechnology] market capitalization is $26.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, QTTB is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 6 TA indicator(s) are bullish while QTTB’s TA Score has 5 bullish TA indicator(s).

  • MESO’s TA Score: 6 bullish, 4 bearish.
  • QTTB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MESO is a better buy in the short-term than QTTB.

Price Growth

MESO (@Biotechnology) experienced а +32.58% price change this week, while QTTB (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MESO is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($2.13B) has a higher market cap than QTTB($27M). MESO YTD gains are higher at: -17.374 vs. QTTB (-35.756). QTTB has higher annual earnings (EBITDA): -40.39M vs. MESO (-77.78M). QTTB has more cash in the bank: 65.5M vs. MESO (37.7M). QTTB has less debt than MESO: QTTB (18.8M) vs MESO (126M). MESO has higher revenues than QTTB: MESO (5.67M) vs QTTB (0).
MESOQTTBMESO / QTTB
Capitalization2.13B27M7,881%
EBITDA-77.78M-40.39M193%
Gain YTD-17.374-35.75649%
P/E RatioN/AN/A-
Revenue5.67M0-
Total Cash37.7M65.5M58%
Total Debt126M18.8M670%
FUNDAMENTALS RATINGS
MESO vs QTTB: Fundamental Ratings
MESO
QTTB
OUTLOOK RATING
1..100
4397
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
3753
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (43) in the null industry is somewhat better than the same rating for MESO (88) in the Biotechnology industry. This means that QTTB’s stock grew somewhat faster than MESO’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as MESO (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to MESO’s over the last 12 months.

MESO's SMR Rating (95) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

MESO's Price Growth Rating (37) in the Biotechnology industry is in the same range as QTTB (53) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

MESO's P/E Growth Rating (97) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that MESO’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MESOQTTB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSJAX16.180.20
+1.25%
JHancock Small Cap Dynamic Growth A
GFVSX16.130.06
+0.37%
Goldman Sachs Focused Value Instl
PAWAX76.570.21
+0.28%
T. Rowe Price All-Cap Opportunities-Adv
JIJAX14.85-0.01
-0.07%
JHancock International Dynamic Gr A
FARCX14.95-0.02
-0.13%
Nuveen Real Estate Securities I

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
-3.65%
QTTB - MESO
51%
Loosely correlated
-4.33%
AVTX - MESO
32%
Poorly correlated
+0.90%
ZURA - MESO
30%
Poorly correlated
-2.38%
PYPD - MESO
29%
Poorly correlated
-1.60%
CGEM - MESO
29%
Poorly correlated
-1.80%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-4.33%
CLRB - QTTB
64%
Loosely correlated
-4.86%
MESO - QTTB
51%
Loosely correlated
-3.65%
STOK - QTTB
49%
Loosely correlated
-3.03%
ADCT - QTTB
46%
Loosely correlated
+1.55%
ANAB - QTTB
39%
Loosely correlated
-0.19%
More